Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RF16001 local infiltration for analgesia after total hip arthroplasty (Phase II)
ChiCTR2500107498Phase 2Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RF16001 in postoperative pain (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Total dosage of morphine. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
RF16001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500107498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107498.